182 related articles for article (PubMed ID: 32855975)
1. Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma.
Ene CD; Tampa M; Nicolae I; Mitran CI; Mitran MI; Matei C; Caruntu A; Caruntu C; Georgescu SR
J Immunol Res; 2020; 2020():2491265. PubMed ID: 32855975
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
5. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Ang CW; Notermans NC; Van Doorn PA; Jacobs BC; Van den Berg LH
Neurology; 2001 Nov; 57(10):1909-12. PubMed ID: 11723289
[TBL] [Abstract][Full Text] [Related]
6. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
7. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Illa I; Rojas R; Gallardo E; Serrano C; Graus F
Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
[TBL] [Abstract][Full Text] [Related]
8. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
9. Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis.
Oktar AÇ; Selçuk Ö; Tunç CE; Işıldak Ş; Şanlı E; Yılmaz V; Tüzün BB; Kürtüncü M; Çokar AÖ; Tüzün E
Turk J Med Sci; 2021 Oct; 51(5):2570-2574. PubMed ID: 34174799
[TBL] [Abstract][Full Text] [Related]
10. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies.
Conrad K; Schneider H; Ziemssen T; Talaska T; Reinhold D; Humbel RL; Roggenbuck D
Ann N Y Acad Sci; 2007 Aug; 1109():256-64. PubMed ID: 17785314
[TBL] [Abstract][Full Text] [Related]
11. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside reactive antibodies in the neuropathy associated with celiac disease.
Alaedini A; Green PH; Sander HW; Hays AP; Gamboa ET; Fasano A; Sonnenberg M; Lewis LD; Latov N
J Neuroimmunol; 2002 Jun; 127(1-2):145-8. PubMed ID: 12044986
[TBL] [Abstract][Full Text] [Related]
13. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside reactive antibodies of IgG and IgM class in sera of patients with differentiated thyroid cancer.
Lewartowska A; Pacuszka T; Adler G; Panasiewicz M; Wojciechowska W
Immunol Lett; 2002 Feb; 80(2):129-32. PubMed ID: 11750045
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
18. Cell surface reactive human monoclonal antibody directed to human melanoma-associated gangliosides.
Abdel-Wahab Z; Li WP; Darrow T; Nudelman ED; Towell A; Seigler HF
Melanoma Res; 1993 Dec; 3(6):415-23. PubMed ID: 8161881
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
20. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]